微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 24.64% | 3.61% | -2% | 116/140 | 52.37% | 迈普医学 | 78.96% | 行业排名> |
| 2025-12-31 | 25.15% | -3.49% | 0.16% | 116/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 25.11% | -4.58% | -0.41% | 115/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 25.21% | -5.41% | 5.99% | 117/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 23.79% | -3.63% | -8.71% | 117/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 26.06% | -1.61% | -0.98% | 116/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 26.31% | -4.95% | -1.28% | 112/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 26.65% | -2.74% | 7.98% | 116/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 24.68% | -5.85% | -6.8% | 113/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 26.48% | 0.17% | -4.34% | 116/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 27.68% | 6.73% | 1.02% | 110/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 27.41% | 4.69% | 4.54% | 112/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 26.22% | 2.11% | -0.85% | 109/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 26.44% | 9.02% | 1.93% | 116/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 25.94% | 10.01% | -0.92% | 109/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 26.18% | 18.23% | 1.97% | 113/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 25.67% | 3.74% | 5.87% | 102/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 24.25% | 4.19% | 2.86% | 120/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 23.58% | 0.12% | 6.47% | 104/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 22.14% | -2.19% | -10.53% | 114/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 24.75% | 7.56% | 6.32% | 92/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 23.28% | 9.63% | -1.15% | 123/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 23.55% | 8.24% | 4.01% | 87/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 22.64% | 4.17% | -1.61% | 108/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 23.01% | 5.36% | 8.37% | 76/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 21.23% | 6.18% | -2.41% | 116/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 21.76% | 8.02% | 0.11% | 65/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 21.73% | 14.36% | -0.49% | 74/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 21.84% | 14.16% | 9.22% | 56/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 20% | 0.73% | -0.72% | 110/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 20.14% | 4.31% | 5.98% | 54/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 19% | -1.9% | -0.66% | 60/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 19.13% | -4.27% | -3.64% | 52/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 19.85% | -4.5% | 2.81% | 103/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 19.31% | -6.58% | -0.33% | 48/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 19.37% | -6.05% | -3.06% | 59/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 19.98% | -1.68% | -3.87% | 44/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 20.79% | -6.65% | 0.57% | 78/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 20.67% | -6.92% | 0.25% | 39/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 20.62% | -6.73% | 1.45% | 48/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 20.32% | -8.82% | -8.74% | 34/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |